Compare CTNM & CHCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CTNM | CHCT |
|---|---|---|
| Founded | 2009 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Real Estate Investment Trusts |
| Sector | | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 489.4M | 511.7M |
| IPO Year | 2024 | 2015 |
| Metric | CTNM | CHCT |
|---|---|---|
| Price | $15.00 | $18.49 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 4 | 3 |
| Target Price | ★ $19.00 | $18.00 |
| AVG Volume (30 Days) | ★ 417.0K | 167.6K |
| Earning Date | 05-13-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 11.07% |
| EPS Growth | 0.46 | ★ 134.78 |
| EPS | N/A | ★ 0.07 |
| Revenue | N/A | ★ $121,195,000.00 |
| Revenue This Year | N/A | $9.06 |
| Revenue Next Year | N/A | $8.61 |
| P/E Ratio | ★ N/A | $261.86 |
| Revenue Growth | N/A | ★ 4.67 |
| 52 Week Low | $3.72 | $13.23 |
| 52 Week High | $16.33 | $18.39 |
| Indicator | CTNM | CHCT |
|---|---|---|
| Relative Strength Index (RSI) | 68.54 | 66.02 |
| Support Level | $11.82 | $16.45 |
| Resistance Level | $15.60 | N/A |
| Average True Range (ATR) | 1.08 | 0.39 |
| MACD | 0.35 | 0.07 |
| Stochastic Oscillator | 88.91 | 98.71 |
Contineum Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the development of oral small-molecule therapies for neurological, inflammatory, and immunological conditions. The company focuses on developing selective compounds targeting challenging molecular pathways and has built a portfolio of small molecule drug candidates. Its pipeline includes drug candidates in clinical development, such as PIPE-791, an LPA1 receptor antagonist being studied for idiopathic pulmonary fibrosis and chronic pain, and PIPE-307, an M1 receptor inhibitor being evaluated for relapsing-remitting multiple sclerosis and other depressive disorders.
Community Healthcare Trust Inc is an integrated healthcare real estate company in the United States. The company owns and acquires, or finances, real estate properties that are leased to hospitals, doctors, healthcare systems, or other healthcare service providers in non-urban markets. The company derives the majority of its revenues from its real estate property and mortgage notes portfolio. The company's rental and mortgage interest income is recognized based on contractual arrangements with its tenants and borrowers.